Sign in
Taking peopleNo phase

Phone app to support long-term care for people with pulmonary embolism

Tests a smartphone app for managing pulmonary thromboembolism in adults over time.

Key facts

Who runs it
Navy General Hospital, Beijing
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
Status
Recruiting
People taking part
2,972 people, planned
Started
20 Aug 2026
Expected to end
30 Sept 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • mobile venous thromboembolism application (mVTEA)
Record updated
9 September 2026

Who can take part

The trial is looking for adults in hospital with a blood clot in the lungs (pulmonary thromboembolism, PTE), shown on imaging. It tests a mobile health app for long-term care after discharge.

Age
18 years and older
Sex
All
Disease stage
PTE confirmed by imaging. It must be newly diagnosed during this hospital stay, or an earlier PTE with a clot still seen on imaging.
Main reasons for not taking part
  • Earlier PTE together with CTEPH (long-term high blood pressure in the lungs caused by clots)
  • Intellectual disability or other serious illness that stops the person from living on their own
  • Not able to use smartphones, tablets or other smart devices
  • Pregnant or breastfeeding
  • Took part in similar trials, or taking part in another clinical trial now
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Inpatients aged ≥18 years
  • PTE confirmed through imaging examinations, meeting at least one of the following criteria: a.Newly diagnosed PTE during the current hospitalization; b. Prior PTE with imaging evidence of residual thrombus
  • Signed informed consent

Who cannot take part

  • Previous PTE combined with CTEPH
  • Mental retardation or a combination of other serious illnesses that make them incapable of living on their own
  • Inability to use smartphones, computer tablets and other smart devices
  • Being pregnant or breastfeeding
  • Have participated in similar trials or are undergoing other clinical trials

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Venous thromboembolism or pulmonary thromboembolisms or digital health

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.

Read full original descriptionShow less

This study aims to evaluate the effects of a smart technology-assisted, patient-centered mobile health application for pulmonary thromboembolism management (mPEA) on the long-term outcomes of patients with pulmonary thromboembolism (PTE). The findings are expected to inform clinical practice and provide an evidence base for the long-term management of patients with PTE.

The 2 groups in the trial

  • mPEA Management GroupTreatment being tested

    Patients randomly assigned to the mPEA management group will be discharged with mPEA-assisted patient-centered PTE management.

    Treatment: mobile venous thromboembolism application (mVTEA)

  • Routine Management GroupNo study treatment, for comparison

    Patients randomly assigned to the routine management group will be given routine post-discharge management in accordance with local clinical practice.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism:A Multicenter, Randomized Controlled Trial
Plain-language title
Phone app to support long-term care for people with pulmonary embolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06382038, who can take part
Record updated
9 September 2026